101 assets in Metastatic Malignant Neoplasm In The Brain

Therapeutic assets addressing Metastatic Malignant Neoplasm In The Brain, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Olutasidenib Metastatic Malignant Neoplasm In The Brain	Rigel Pharmaceuticals	P2	CCC (53)
Opnurasib Metastatic Malignant Neoplasm In The Brain	Maastricht University Medical Center	P2	CCC (53)
rad101 Metastatic Malignant Neoplasm In The Brain	Radiopharm Theranostics, Ltd	P2	CCC (53)
Sacituzumab Tirumotecan Metastatic Malignant Neoplasm In The Brain	Zhejiang Cancer Hospital	P2	CCC (53)
Shr-A1921 Metastatic Malignant Neoplasm In The Brain	Fudan University	P2	CCC (53)
Tarlatamab Metastatic Malignant Neoplasm In The Brain	Maastricht University Medical Center	P2	CCC (53)
Utidelone Metastatic Malignant Neoplasm In The Brain	Tianjin Medical University Cancer Institute and Hospital	P2	CCC (53)
Valganciclovir Metastatic Malignant Neoplasm In The Brain	The Methodist Hospital Research Institute	P2	CCC (53)
Aguix Metastatic Malignant Neoplasm In The Brain	Brigham and Women's Hospital	P2	CCC (51)
Catequentinib Metastatic Malignant Neoplasm In The Brain	The First People's Hospital of Lianyungang	P2	CCC (51)
Cobimetinib Metastatic Malignant Neoplasm In The Brain	Technische Universität Dresden	P2	CCC (51)
Datopotamab Deruxtecan Metastatic Malignant Neoplasm In The Brain	Latin American Cooperative Oncology Group	P2	CCC (51)
Ensartinib Metastatic Malignant Neoplasm In The Brain	Fudan University	P2	CCC (51)
Lenvatinib Metastatic Malignant Neoplasm In The Brain	M.D. Anderson Cancer Center	P2	CCC (51)
Neratinib Metastatic Malignant Neoplasm In The Brain	Jules Bordet Institute	P2	CCC (51)
qbs72s Metastatic Malignant Neoplasm In The Brain	Stanford University	P2	CCC (51)
Sgm-101 Metastatic Malignant Neoplasm In The Brain	Leiden University Medical Center	P2	CCC (51)
Trametinib Metastatic Malignant Neoplasm In The Brain	Canadian Cancer Trials Group	P2	CCC (51)
TZ-3321 Metastatic Malignant Neoplasm In The Brain	Washington University School of Medicine	P2	CCC (51)
Repotrectinib Metastatic Malignant Neoplasm In The Brain	MedSIR	P2	CCC (50)
neo212 Metastatic Malignant Neoplasm In The Brain	Neonc Technologies, Inc.	P1/2	CCC (48)
Olaparib Metastatic Malignant Neoplasm In The Brain	Colette Shen	P1/2	CC (47)
Alectinib Metastatic Malignant Neoplasm In The Brain	Joshua Palmer	P1/2	CC (43)
Alpelisib Metastatic Malignant Neoplasm In The Brain	M.D. Anderson Cancer Center	P1	CC (43)
ao-252 Metastatic Malignant Neoplasm In The Brain	A2A Pharmaceuticals Inc.	P1	CC (43)
Avutometinib Metastatic Malignant Neoplasm In The Brain	University of Utah	P1/2	CC (43)
Berzosertib Metastatic Malignant Neoplasm In The Brain	National Cancer Institute (NCI)	P1	CC (43)
Cetuximab Metastatic Malignant Neoplasm In The Brain	Institut de Recherches Internationales Servier	P1/2	CC (43)
Defactinib Metastatic Malignant Neoplasm In The Brain	University of Utah	P1/2	CC (43)
Fludarabine Metastatic Malignant Neoplasm In The Brain	Essen Biotech	P1/2	CC (43)
iam1363 Metastatic Malignant Neoplasm In The Brain	Iambic Therapeutics, Inc	P1	CC (43)
L-Tryptophan, 1-(2-(Fluoro-18F)Ethyl)- Metastatic Malignant Neoplasm In The Brain	Barbara Ann Karmanos Cancer Institute	P1	CC (43)
Panitumumab Metastatic Malignant Neoplasm In The Brain	Institut de Recherches Internationales Servier	P1/2	CC (43)
s241656 Metastatic Malignant Neoplasm In The Brain	Institut de Recherches Internationales Servier	P1/2	CC (43)
Sapanisertib Metastatic Malignant Neoplasm In The Brain	National Cancer Institute (NCI)	P1	CC (43)
Telaglenastat Metastatic Malignant Neoplasm In The Brain	National Cancer Institute (NCI)	P1	CC (43)
TIL Metastatic Malignant Neoplasm In The Brain	Essen Biotech	P1/2	CC (43)
utd1 Metastatic Malignant Neoplasm In The Brain	Hunan Cancer Hospital	P1/2	CC (43)
Ropidoxuridine Metastatic Malignant Neoplasm In The Brain	National Cancer Institute (NCI)	P1	CC (41)
18f-αvβ6-bp Metastatic Malignant Neoplasm In The Brain	University of California, Davis	P1	C (39)
[F-18]MeFAMP Metastatic Malignant Neoplasm In The Brain	University of Alabama at Birmingham	Early P1	C (39)
Pebezertinib Metastatic Malignant Neoplasm In The Brain	Blueprint Medicines Corporation	P1	C (39)
qh101 cell Metastatic Malignant Neoplasm In The Brain	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Early P1	C (39)
Risvutatug Rezetecan Metastatic Malignant Neoplasm In The Brain	Nader Sanai	Early P1	C (39)
Sv-Br-1-Gm Metastatic Malignant Neoplasm In The Brain	Medical College of Wisconsin	P1	C (39)
Autologous Nk Cells Metastatic Malignant Neoplasm In The Brain	Peking University Third Hospital	N/A	D (30)
Nitroglycerin Tablets Metastatic Malignant Neoplasm In The Brain	Instituto Nacional de Cancerologia de Mexico	N/A	D (30)
Soluble Fluorescein Metastatic Malignant Neoplasm In The Brain	Mayo Clinic	N/A	D (30)
E-6201 Metastatic Malignant Neoplasm In The Brain	Mayo Clinic	P1	D (27)
Trotabresib Metastatic Malignant Neoplasm In The Brain	Northwestern University	P1	D (23)

Showing 51 to 100 of 101 assets

PreviousPage 2 of 3Next